Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aryl Nitrile Compound. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel palladium-catalyzed cyanation using potassium ferrocyanide ensures high purity and yield. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116332794A reveals a safe Pd-catalyzed cyanation using K4[Fe(CN)6], offering high purity aryl nitriles for pharma intermediates with reduced toxicity.
Patent CN110240554A enables high-purity α-sulfide aryl acetonitrile synthesis with mild conditions, reducing manufacturing costs and ensuring supply chain continuity for pharmaceutical intermediates.